Crypto exchange Kraken is not in a hurry to pursue a U.S. public listing, even as other digital asset firms are taking advantage of a friendlier regulatory environment and improving market conditions.
Financial Strength and Independence
Kraken co-CEO Arjun Sethi told Yahoo Finance that the company is financially sound and well-capitalized as a private entity.
“We have enough capital on our balance sheet today as a private company,” Sethi said. “We don’t race to the door as quickly as possible.”
The firm emphasizes its risk management expertise and ability to operate independently, without feeling pressure from the recent wave of crypto IPOs.
Market Context: IPOs and Regulatory Shifts
Several crypto companies have gone public in 2025, fueled by a friendlier policy climate under the Trump administration and successful IPOs from peers. Notably:
- Circle, a stablecoin issuer, saw shares surge over 160% post-debut in June.
- Grayscale filed for a U.S. listing on Thursday.
- Other recent debuts include Gemini, Bullish, eToro, Figure, and custody firm BitGo.
Sethi views these IPOs as educational opportunities for the market, demonstrating both what works and what doesn’t in crypto business models, profit margins, and long-term strategy.
Kraken’s Background
Founded in 2011, Kraken has raised $530 million in funding, including a $500 million round in September 2025 that valued the company at $15 billion. Despite market speculation about an IPO as early as Q1 2026, Sethi insists the company is under no pressure to go public immediately.
“We don’t have the fear of missing out because everyone else is doing it,” he added.
Market Volatility and Bitcoin Correction
Bitcoin (BTC) has recently fallen over 4% to around $97,000, marking a 22% correction from its early October peak of over $126,000. While such dips often impact exchange volumes, Sethi expressed confidence in the long-term thesis of crypto.
“What’s much more important is the thesis behind why you’d want to buy Bitcoin or Ethereum, or any of these assets, versus holding a dollar or any other shares,” he said.
Kraken’s patient approach highlights a focus on strategic growth and market education, rather than chasing immediate listing opportunities.